Digestive & Liver Health

Speakers Program Gastrointestinal and liver diseases are remarkably common and create a remarkable burden of illness for affected patients. Expand your hospital’s discussion around these disorders by scheduling a U-M Digestive and Liver Health faculty member to speak at your next Grand Rounds. Email us at UMGIspeakers@med.umich.edu to request a speaker and topic. If you have questions please call us at 734-936-4775.

LUMINAL GI

Allan Barbish, M.D.

Shrinivas Bishu, M.D.

William D. Chey, M.D.

Grace Elta, M.D.

• • • • •

• Optimizing Remicade and Humira in IBD; the role of therapeutic drug monitoring • New therapeutics in IBD: The state of pipeline drugs • Operative indications for Ulcerative Colitis • Management of post- op Crohn’s disease

• Diet & lifestyle in the management of IBS • Evidence based medical treatment of IBS • Microbiome based treatment strategies for IBS • H. pylori infection • Treatment of bloating

• Pancreatic Biliary Topics

Shanti Eswaran, M.D.

William Hasler, M.D.

Peter Higgins, M.D., PhD

John Kao, M.D.

• Celiac disease • Dietary treatments for IBS

• Gastroparesis

• New Therapies and Clinical Trials in IBD • Optimizing Therapies in IBD • Therapies Beyond Anti-TNFs in IBD • Combination Therapy in IBD – When and How • Initiating and Maintaining Remission with Biologics in IBD

• Celiac Disease • H. pylori infection • C. difficile infection/ fecal transplant

GERD Chronic IBD Pain IBS Colon Cancer Screening Diarrhea/Constipation

www.UofMHealth.org/gi

Speakers Program LUMINAL GI continued

Jami Kinnucan, M.D.

Ryan J. Law, D.O.

Michael Rice, M.D.

Megan Riehl, PsyD

• Sleep disturbances in IBD • Marijuana use in IBD • Pregnancy and Breastfeeding in IBD

• Endoscopic Management of Obesity • Peroral Endoscopic Myotomy for Achalasia • Endoscopic Submucosal Dissection of Rectal and Gastric Lesions • Utility of Double Balloon Enteroscopy

• Obscure GI bleeding/ Small bowel bleeding • Evaluation of the Small bowel with capsule endoscopy and Double Balloon Enteroscopy • Endoscopic Evaluation and Management of Crohn’s Disease

GI Behavioral Health strategies for: • Functional GI Disorders • IBD

Richard Saad, M.D.

Phillip Schoenfeld, M.D.

Neil Sheth, M.D.

Ryan Stidham, M.D.

• Small intestinal bacterial overgrowth

• Screening and surveillance for colorectal cancer

• Capsule endoscopy and double balloon enteroscopy in patients with chronic small intestinal bleeding.

• IBD (therapeutics, diagnostics, prognostics, clinical trial updates) • Cancer Screening • Personalizing care in IBD

www.UofMHealth.org/gi

HEPATOLOGY

Joel Rubenstein, M.D. • Barrett’s Esophagus screening and management • Adverse Effects of PPIs • Management of GERD • Eosinophilic Esophagitis • Management of Dysphagia • Achalasia

Hari S. Conjeevaram, M.D., Ph.D.

Hellan Kwon, M.D. • Non-alcoholic fatty liver disease • Cirrhosis and related complications

• Non-Alcoholic Fatty Liver Disease (NAFLD) • Hepatitis C • Hepatitis B • Complications of Cirrhosis

Anna S. F. Lok, M.D., F.R.C.P. • Hepatitis B • Hepatitis C Broad Liver Topics: • Viral Hepatitis • Fatty Liver • Cirrhosis and Liver Transplant • Liver Tumors

Elena Stoffel, M.D.

Jessica Mellinger, M.D.

Neehar Parikh, M.D.

Pratima Sharma, M.D.

• Hereditary GI Cancer Syndromes

• Alcoholic Liver Disease • Cirrhosis Management

• Chronic Liver Disease Management • Liver Cancer • Liver Transplantation

• Cirrhosis and complications of portal hypertension, hepatorenal syndrome, liver transplantation, viral hepatitis or any other liver related topic.

Grace Su, M.D. • Alcoholic Hepatitis • Autoimmune Liver Disease • Non Alcoholic Fatty Liver Disease

www.UofMHealth.org/gi

Founded in 1947, the Division of Gastroenterology has established a number of programs and clinics that provide specialized support for patients and their caregivers. These include: Behavioral Health Program Cirrhosis Program Crohn’s and Colitis IBD Program Digestive Disorders Nutrition and Lifestyle Program Esophageal Disorders Program Functional Bowel Disorders Program Hepatology Program Liver Transplant Program Medical Procedures Unit Michigan Bowel Control Program Motility Disorders Pancreatic Biliary Program Small Bowel Program Viral Hepatitis Program Wilson Disease Center of Excellence

For additional information visit www.UofMHealth.org/provider

Executive Officers of the University of Michigan Health System: Marschall S. Runge, M.D., Ph.D., Executive Vice President for Medical Affairs, Dean, University of Michigan Medical School; David A. Spahlinger, M.D., Executive Vice Dean of Clinical Affairs, President, Clinical Enterprise; Kathleen Potempa, Ph.D., Dean, School of Nursing.

Regents of the University of Michigan: Michael J. Behm, Mark J. Bernstein, Laurence B. Deitch, Shauna Ryder Diggs, Denise Ilitch, Andrea Fischer Newman, Andrew C. Richner, Katherine E. White, Mark S. Schlissel, ex officio.

The University of Michigan, as an equal opportunity/affirmative action employer, complies with all applicable federal and state laws regarding nondiscrimination and affirmative action. The University of Michigan is committed to a policy of equal opportunity for all persons and does not discriminate on the basis of race, color, national origin, age, marital status, sex, sexual orientation, gender identity, gender expression, disability, religion, height, weight, or veteran status in employment, educational programs and activities, and admissions. Inquiries or complaints may be addressed to the Senior Director for Institutional Equity, and Title IX/Section 504/ADA Coordinator, Office for Institutional Equity, 2072 Administrative Services Building, Ann Arbor, Michigan 48109-1432, 734-763-0235, TTY 734-647-1388, institutional.equity@umich.edu. For other University of Michigan information call 734-764-1817.

Š 2016 Regents of the University of Michigan.

www.UofMHealth.org/gi